Target intelligence / Profile preview

Marker of proliferation Ki-67 protein (Ki-67)

Target
Ki-67
Molecular classification
Nuclear protein, DNA-binding protein, Cell cycle-associated protein, Other
01

Overview

The marker of proliferation Ki-67 protein is a large, predominantly unstructured nuclear protein encoded by the MKI67 gene in humans[6][7][4][5]. It contains characteristic domains, including a forkhead-associated (FHA) domain, a PP1-binding domain, and a highly repetitive region unique to the protein, as well as a chromatin-binding C-terminal region[4][5][2]. Ki-67 is present during all active phases of the cell cycle (G1, S, G2, and M phases) but absent in quiescent cells (G0), making it a robust indicator of cell proliferation[2][3][6]. Although historically thought to be required for proliferation, genetic studies reveal Ki-67 is not essential for cell division but rather plays roles in nucleolar structure, perichromosomal layer formation, and possibly liquid–liquid phase separation[1][2][5]. Due to its strong correlation with cellular proliferation, Ki-67 is widely used in oncology as a diagnostic, prognostic, and grading marker, with high expression correlating with tumor aggressiveness[3][6]. There are no known drugs that directly target Ki-67, and it is not considered a therapeutic target but rather a valuable biomarker[3].

Other names
Ki-67MKI67Antigen Kiel 67Proliferation marker protein Ki-67pKi67
02

Biological functions

Cell proliferationCell cycle regulationChromatin organizationRegulation of ribosomal RNA synthesisNucleolar structure organization
03

Disease associations

CancerOther (used as a diagnostic and prognostic marker in oncology)
04

Safety considerations

Not a therapeutic target; no direct drug targeting, thus no specific therapeutic safety concernsPotential for variability and interpretation challenges in immunohistochemistry staining
05

Biomarkers

Cell proliferation index in tumorsPrognostic indicator in breast cancer and other malignanciesStratification of neuroendocrine tumors (e.g., pancreatic NET grading)

Beyond the preview

Go deeper on Marker of proliferation Ki-67 protein (Ki-67).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Marker of proliferation Ki-67 protein (Ki-67).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call